• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Iranian Journal of Immunology
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 15 (2018)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 14 (2017)
Volume Volume 13 (2016)
Volume Volume 12 (2015)
Volume Volume 11 (2014)
Volume Volume 10 (2013)
Volume Volume 9 (2012)
Volume Volume 8 (2011)
Volume Volume 7 (2010)
Volume Volume 6 (2009)
Volume Volume 5 (2008)
Volume Volume 4 (2007)
Volume Volume 3 (2006)
Volume Volume 2 (2005)
Volume Volume 1 (2004)
Khodabandeh Shahraki, P., Zare, Y., Azarpira, N., Hosseinzadeh, M., Farjadian, S. (2018). Prognostic Value of HLA-G in Malignant Liver and Pancreas Lesions. Iranian Journal of Immunology, 15(1), 28-37.
Parisa Khodabandeh Shahraki; Yasmin Zare; Negar Azarpira; Massood Hosseinzadeh; Shirin Farjadian. "Prognostic Value of HLA-G in Malignant Liver and Pancreas Lesions". Iranian Journal of Immunology, 15, 1, 2018, 28-37.
Khodabandeh Shahraki, P., Zare, Y., Azarpira, N., Hosseinzadeh, M., Farjadian, S. (2018). 'Prognostic Value of HLA-G in Malignant Liver and Pancreas Lesions', Iranian Journal of Immunology, 15(1), pp. 28-37.
Khodabandeh Shahraki, P., Zare, Y., Azarpira, N., Hosseinzadeh, M., Farjadian, S. Prognostic Value of HLA-G in Malignant Liver and Pancreas Lesions. Iranian Journal of Immunology, 2018; 15(1): 28-37.

Prognostic Value of HLA-G in Malignant Liver and Pancreas Lesions

Article 3, Volume 15, Issue 1, Winter 2018, Page 28-37  XML PDF (861.81 K)
Document Type: Original Article
Authors
Parisa Khodabandeh Shahraki1; Yasmin Zare1; Negar Azarpira2; Massood Hosseinzadeh3; Shirin Farjadian email 1
1Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
2Organ Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
3Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract
Background: Human leukocyte antigen (HLA)-G is a nonclassical HLA class I molecule with modulatory effects on NK and T cells. Because HLA-G expression is frequently detected in different solid tumors, it may be involved in tumor immune evasion. Objective: This study was designed to elucidate the prognostic value of HLA-G in hepatocellular carcinoma (HCC) and pancreatic adenocarcinoma (PADC). The influence of hepatitis B virus (HBV) infection on HLA-G expression was also evaluated in patients with HCC. Methods: HLA-G expression was investigated in tumor tissues from patients with HCC (n=74) or PADC (n=42) with immunohistochemical techniques. The presence of HBV genome was also examined in HCC tumor tissues by PCR. Results: HLA-G expression was detected in 66% of PADC and in 31% of HCC samples. In contrast to HCC, HLA-G overexpression was associated with advanced stages and grades in PADC. HBV genome was detected in 31% of HCC samples but we found no correlation between HLA-G expression and the presence of HBV genome in these tumors. Conclusion: Our findings showed that HLA-G overexpression in tumor tissue correlated with poor prognosis in PADC. HLA-G expression is apparently affected by the patient’s genetic background and other epigenetic factors rather than by HBV infection.
Statistics
Article View: 668
PDF Download: 722
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by sinaweb.